There are 807 resources available
185MO - Preliminary results of niraparib combined with brivanib or toripalimab dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101): An open-label, two cohorts, phase II clinical trial
Presenter: Dongling Zou
Session: Mini Oral session: Gynaecological tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 184MO and 185MO
Presenter: Alexandra Leary
Session: Mini Oral session: Gynaecological tumours
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Smruti Koppikar
Session: Mini Oral session: Gynaecological tumours
Resources:
Slides
Webcast
Hypofractionation: The concept (overview, biology and cost)
Presenter: Shankar Siva
Session: Hypofractionation in radiotherapy
Resources:
Slides
Webcast
Optimal diagnostic pathway for oncogenic driven lung cancer
Presenter: Daniel Shao Weng Tan
Session: Lung cancer in non-smokers
Resources:
Slides
Webcast
Ovarian cancer
Presenter: Junzo Hamanishi
Session: Immunotherapy in gynecological cancers: Where do we stand?
Resources:
Slides
Webcast
273MO - A supportive and expanding nurse led model of care, symptom urgent review clinic (SURC)
Presenter: Lisa Taylor
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
YO1 - Locally Advanced Breast Cancer Outcome During Second Trimester of Pregnancy
Presenter: Jesilyn Palec
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Abstract
Slides
Webcast
135O - A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced MIBC
Presenter: Feng Wen
Session: Proffered Paper session: Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Breast: State of the art in 2022
Presenter: Yong Bae Kim
Session: Hypofractionation in radiotherapy
Resources:
Slides
Webcast